Diabetic Nephropathy
Information
- Disease name
- Diabetic Nephropathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06097351 | Active, not recruiting | Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value | June 1, 2020 | January 31, 2024 | |
| NCT06123871 | Active, not recruiting | Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value | June 1, 2020 | January 31, 2024 | |
| NCT00044148 | Completed | Phase 2 | The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes | July 16, 2002 | April 28, 2004 |
| NCT00063583 | Completed | Phase 1/Phase 2 | Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes | June 2003 | March 2009 |
| NCT00067678 | Completed | Phase 1/Phase 2 | Soy Protein in Early Diabetic Nephropathy | July 2001 | June 2003 |
| NCT00067886 | Completed | Matrix Metalloproteinases and Diabetic Nephropathy | March 2003 | December 2008 | |
| NCT00097955 | Completed | Phase 2 | Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria | October 2004 | April 2007 |
| NCT00106561 | Completed | Phase 2/Phase 3 | Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney | January 2002 | September 2004 |
| NCT00118976 | Completed | N/A | Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease | March 2005 | September 2006 |
| NCT00130208 | Completed | Phase 3 | Effect of Sulodexide in Early Diabetic Nephropathy | August 2005 | February 2008 |
| NCT02829177 | Completed | Phase 4 | Microalbuminuria and Allopurinol in Type 1 Diabetes | September 2014 | September 20, 2017 |
| NCT00024921 | Completed | The Genetics of Kidneys in Diabetes (GoKinD) Study | |||
| NCT01726816 | Completed | Phase 2 | Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy | October 2012 | September 2014 |
| NCT01756703 | Completed | Phase 2 | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria | November 2012 | August 2014 |
| NCT01756716 | Completed | Phase 2 | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR | December 2012 | September 2014 |
| NCT01774981 | Completed | Phase 1/Phase 2 | Study of LY3016859 in Participants With Diabetic Nephropathy | March 2013 | August 2015 |
| NCT01810822 | Completed | Sex-specific Association With Kidney Disease | May 1994 | October 2012 | |
| NCT01843387 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy | July 2013 | September 2015 |
| NCT01869881 | Completed | Phase 4 | Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) | February 1, 2013 | January 28, 2015 |
| NCT01875341 | Completed | Phase 3 | Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. | December 2004 | February 2015 |
| NCT01889277 | Completed | Phase 1/Phase 2 | Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy | July 2013 | January 2015 |
| NCT01923597 | Completed | Phase 2 | Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. | November 2013 | March 2015 |
| NCT01935167 | Completed | Phase 2 | To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy | October 2013 | February 2015 |
| NCT02040441 | Completed | Phase 2/Phase 3 | Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria | March 2014 | November 2018 |
| NCT02065791 | Completed | Phase 3 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | February 17, 2014 | October 30, 2018 |
| NCT02150707 | Completed | The Differential Effects of Diabetes Therapy on Inflammation | May 2014 | December 2015 | |
| NCT02194790 | Completed | N/A | Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. | December 2012 | December 2013 |
| NCT02204280 | Completed | The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy | August 2014 | July 2015 | |
| NCT02205372 | Completed | Phase 1/Phase 2 | Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy | July 2014 | August 2015 |
| NCT02251067 | Completed | Phase 2 | Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients | September 2014 | March 2017 |
| NCT02276196 | Completed | Phase 4 | Effect of LIXIsenatide on the Renal System | September 2014 | April 2016 |
| NCT02327754 | Completed | Phase 2 | Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout | December 2016 | |
| NCT02345057 | Completed | Phase 2 | A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria | January 2015 | July 2016 |
| NCT02384902 | Completed | N/A | Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients | May 2014 | July 2014 |
| NCT02477163 | Completed | N/A | Ayurvedic Management of Chronic Kidney Disease | January 2014 | April 30, 2022 |
| NCT02502071 | Completed | Phase 4 | Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes | January 2017 | August 2017 |
| NCT02517320 | Completed | Phase 2 | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy | July 2015 | January 2017 |
| NCT02625649 | Completed | Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients | January 2016 | June 2017 | |
| NCT02628106 | Completed | Phase 4 | Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy | December 2015 | February 2016 |
| NCT02676401 | Completed | Phase 2 | An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy | February 2016 | |
| NCT02689778 | Completed | Phase 3 | Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy | March 2016 | December 2019 |
| NCT02704494 | Completed | Early Phase 1 | Resveratrol's Effects in Diabetic Nephropathy | March 2016 | February 2017 |
| NCT02768948 | Completed | N/A | Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? | May 5, 2017 | July 11, 2020 |
| NCT02816762 | Completed | Phase 4 | CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea | June 2016 | December 2020 |
| NCT00004266 | Completed | Phase 3 | Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes | August 1993 | July 1999 |
| NCT02914691 | Completed | Phase 4 | Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes | August 2015 | July 5, 2017 |
| NCT02928250 | Completed | N/A | Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes | August 2015 | |
| NCT03436693 | Completed | Phase 3 | Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy | February 15, 2018 | January 21, 2021 |
| NCT03804879 | Completed | Phase 2 | Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy | December 17, 2018 | May 3, 2021 |
| NCT04027530 | Completed | Phase 4 | Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. | December 10, 2020 | January 9, 2023 |
| NCT04721847 | Completed | N/A | Pain Neuroscience Education in Diabetic Neuropathy | August 13, 2020 | August 31, 2021 |
| NCT04881994 | Completed | Phase 1 | A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution | March 25, 2014 | December 8, 2014 |
| NCT05492630 | Completed | Phase 1 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects | May 24, 2021 | January 4, 2023 |
| NCT05695573 | Completed | Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy | July 5, 2019 | June 1, 2022 | |
| NCT06095544 | Completed | N/A | Enhanced Recovery After Surgery for SPK Transplantation Recipients | January 1, 2021 | June 1, 2023 |
| NCT00140543 | Completed | Phase 3 | European Trial of Immunosuppression in SPK Tx | February 2002 | September 30, 2005 |
| NCT00141453 | Completed | Phase 3 | ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial | April 2003 | January 2009 |
| NCT00171574 | Completed | Phase 4 | Antiproteinuric Effect of Valsartan and Lisinopril | November 2004 | July 2006 |
| NCT00222846 | Completed | N/A | Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study | May 2004 | December 2009 |
| NCT00240019 | Completed | N/A | Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. | December 2003 | April 2006 |
| NCT00253786 | Completed | N/A | Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy | November 11, 2005 | November 27, 2014 |
| NCT00287183 | Completed | Phase 2 | 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria | February 2006 | August 2009 |
| NCT00296296 | Completed | Phase 4 | Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) | June 2005 | October 2014 |
| NCT00301249 | Completed | The Family Investigation of Nephropathy and Diabetes Study | October 1999 | December 2006 | |
| NCT00311870 | Completed | Phase 4 | Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy | March 1993 | April 1999 |
| NCT00312780 | Completed | Phase 2 | Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy | March 2006 | December 2007 |
| NCT00315016 | Completed | Phase 2 | Eplerenone, ACE Inhibition and Albuminuria | January 2007 | July 2011 |
| NCT00317954 | Completed | Phase 4 | Spironolactone in Diabetic Nephropathy | September 2003 | July 2005 |
| NCT00320021 | Completed | Phase 2 | Effect of Pyridorin in Patients With Diabetic Nephropathy | July 2002 | September 2003 |
| NCT00320060 | Completed | Phase 2 | Effect of Pyridorin in Patients With Diabetic Nephropathy | October 2001 | January 2003 |
| NCT00320970 | Completed | N/A | Angiotensin II Antagonism of TGF-Beta 1 | August 2002 | September 2004 |
| NCT00340678 | Completed | Phase 3 | Renoprotection in Early Diabetic Nephropathy in Pima Indians | August 1995 | March 2014 |
| NCT00353600 | Completed | Delaying the Progression of Diabetic Nephropathy in Pima Indians | August 19, 1994 | August 16, 2011 | |
| NCT00361023 | Completed | N/A | Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy | January 2006 | July 2006 |
| NCT00362960 | Completed | Phase 3 | Olmesartan Medoxomil and Diabetic Nephropathy | May 2003 | September 2004 |
| NCT00363987 | Completed | Phase 4 | Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) | May 2006 | June 2009 |
| NCT00364988 | Completed | N/A | Pioglitazone and Losartan Provides Additional Renoprotection | January 2005 | January 2006 |
| NCT00419484 | Completed | Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes | March 2004 | July 2008 | |
| NCT00421733 | Completed | Phase 2 | The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors | December 2006 | June 2009 |
| NCT00484068 | Completed | N/A | Chicken-Diet vs. Enalapril to Reduce Albuminuria | January 2003 | June 2006 |
| NCT00498537 | Completed | N/A | Spironolactone for Reducing Proteinuria in Diabetic Nephropathy | January 2003 | June 2006 |
| NCT00518362 | Completed | N/A | To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) | July 2007 | March 2010 |
| NCT00535925 | Completed | Phase 4 | Nephropathy In Type 2 Diabetes and Cardio-renal Events | October 2005 | May 2019 |
| NCT00544934 | Completed | Phase 1/Phase 2 | Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects | February 2007 | October 2007 |
| NCT00556465 | Completed | Phase 2/Phase 3 | Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy | January 2007 | June 2007 |
| NCT00561704 | Completed | N/A | Adiponectin in Obese Women With T2DN and Effects by RAS Blocker | April 2007 | October 2007 |
| NCT00565318 | Completed | Phase 4 | Benfotiamine in Diabetic Nephropathy | December 2007 | June 2009 |
| NCT00594152 | Completed | Phase 3 | Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) | January 1993 | January 1995 |
| NCT00663949 | Completed | Phase 2/Phase 3 | Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy | February 2006 | January 2008 |
| NCT00664027 | Completed | Phase 2 | Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy | April 30, 2008 | May 31, 2009 |
| NCT00708981 | Completed | N/A | Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) | May 2007 | December 2013 |
| NCT00734253 | Completed | Phase 2 | Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes | August 2008 | August 2010 |
| NCT00738660 | Completed | Phase 3 | Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy | February 2007 | May 2008 |
| NCT00754143 | Completed | Phase 1 | Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy | March 2008 | December 2009 |
| NCT00774904 | Completed | N/A | Adiponectin and Insulin Resistance in Diabetic Nephropathy | April 2007 | November 2007 |
| NCT00782847 | Completed | Phase 3 | Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy | July 2004 | January 2007 |
| NCT00811889 | Completed | Phase 2 | Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease | April 30, 2009 | December 31, 2010 |
| NCT00893425 | Completed | Phase 4 | Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria | January 2008 | April 2009 |
| NCT00914524 | Completed | Phase 2 | Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy | January 2005 | October 2006 |
| NCT00920764 | Completed | Phase 2 | A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors | June 2009 | May 2010 |
| NCT00967629 | Completed | Phase 1 | Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy | June 2009 | February 2010 |
| NCT01003236 | Completed | Phase 2 | Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy | October 2010 | November 2011 |
| NCT01015937 | Completed | N/A | Effect of Turmeric on Diabetic Nephropathy | March 2008 | August 2009 |
| NCT01028287 | Completed | Phase 4 | Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) | May 2009 | July 2011 |
| NCT01068041 | Completed | Phase 2 | Effects of PH3 in Diabetic Nephropathy | August 2010 | September 2015 |
| NCT01109212 | Completed | Phase 2 | The Effects of Bindarit in Diabetic Nephropathy | March 2007 | December 2008 |
| NCT01130727 | Completed | N/A | The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus | May 2010 | February 2012 |
| NCT01163591 | Completed | To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy | January 2009 | October 2009 | |
| NCT01252056 | Completed | Phase 4 | A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy | March 2010 | December 2012 |
| NCT01265563 | Completed | Phase 2 | N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy | January 2011 | December 2016 |
| NCT01328821 | Completed | Phase 1 | Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 | March 2011 | June 2011 |
| NCT01331317 | Completed | Phase 4 | Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy | April 2010 | April 2012 |
| NCT01356849 | Completed | Phase 2 | Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor | April 2011 | August 2012 |
| NCT01371955 | Completed | Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy | January 2011 | March 2013 | |
| NCT01399580 | Completed | Phase 2 | A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy | August 2011 | September 2012 |
| NCT01424319 | Completed | Phase 2 | Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan | August 2011 | July 2012 |
| NCT01440257 | Completed | Phase 2 | A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria | September 2011 | September 2013 |
| NCT01447147 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy | October 2011 | December 2014 |
| NCT01476501 | Completed | Phase 2 | Vitamin D Supplementation in Diabetic Nephropathy | October 2011 | December 2015 |
| NCT01493050 | Completed | Phase 2 | The Effects of Sevelamer Carbonate on Diabetic Nephropathy | February 2012 | December 2013 |
| NCT01588795 | Completed | Phase 4 | Renal Denervation in Diabetic Nephropathy | April 2012 | January 2016 |
| NCT01601236 | Completed | Phase 2 | Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients | May 2012 | March 2016 |
| NCT01667614 | Completed | Phase 2 | Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure | May 2010 | July 2012 |
| NCT01703234 | Completed | Phase 4 | FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients | January 2008 | April 2009 |
| NCT01712061 | Completed | Phase 2 | A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy | December 2012 | September 2014 |
| NCT04125329 | Recruiting | Early Phase 1 | Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy | April 1, 2020 | September 1, 2024 |
| NCT04981613 | Recruiting | N/A | Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy | July 28, 2021 | August 2024 |
| NCT00342927 | Recruiting | Family Investigation of Nephropathy and Diabetes (F.I.N.D.) | March 7, 2001 | ||
| NCT01105858 | Recruiting | Molecular and Clinical Profile of Diabetes Mellitus and Its Complications | November 16, 2010 | ||
| NCT01802034 | Recruiting | Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) | February 2013 | August 2025 | |
| NCT00913393 | Terminated | Phase 2 | Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy | February 2009 | June 2010 |
| NCT01129557 | Terminated | Phase 4 | Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease | September 2009 | December 2012 |
| NCT00171119 | Terminated | Phase 4 | A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril | January 2004 | |
| NCT00557518 | Terminated | Phase 2 | Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria | November 2007 | November 2009 |
| NCT01113801 | Terminated | Phase 2 | A Study in Participants With Diabetic Kidney Disease | July 2010 | July 2014 |
| NCT01858532 | Terminated | Phase 3 | Study Of Diabetic Nephropathy With Atrasentan | May 17, 2013 | March 29, 2018 |
| NCT00065559 | Terminated | N/A | Treatment of Diabetic Nephropathy | April 2003 | December 2004 |
| NCT02156843 | Terminated | Phase 3 | Pyridorin in Diabetic Nephropathy | June 2014 | March 2018 |
| NCT00130312 | Terminated | Phase 4 | Effect of Sulodexide in Overt Diabetic Nephropathy | August 2005 | March 2008 |
| NCT00120328 | Terminated | Phase 3 | To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy | July 2005 | February 2007 |
| NCT00462202 | Terminated | Phase 3 | Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong | April 2007 | March 2008 |
| NCT01779089 | Unknown status | N/A | Minocycline and Proteinuria in Diabetic Nephropathy | February 2009 | March 2016 |
| NCT00497666 | Unknown status | Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study | August 2007 | December 2007 | |
| NCT00498147 | Unknown status | Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program | July 2007 | July 2010 | |
| NCT01796418 | Unknown status | N/A | Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy | March 2013 | |
| NCT01273675 | Unknown status | An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy | September 2010 | ||
| NCT01316068 | Unknown status | Phase 4 | Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients | March 2011 | August 2012 |
| NCT05330390 | Unknown status | Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease | April 4, 2022 | December 31, 2023 | |
| NCT02409511 | Unknown status | Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy) | January 2016 | April 2018 | |
| NCT01458158 | Unknown status | Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease | October 2011 | May 2016 | |
| NCT02035891 | Unknown status | N/A | Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria | December 2013 | June 2023 |
| NCT01566006 | Unknown status | N/A | Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration | April 2012 | August 2013 |
| NCT02501772 | Unknown status | N/A | The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy | September 2014 | December 2019 |
| NCT00870402 | Unknown status | Phase 4 | Aldosterone in Diabetic Nephropathy | March 2009 | March 2010 |
| NCT03407989 | Unknown status | SWIDINEP a Swiss Diabetic Nephropathy Cohort | January 1, 2014 | January 1, 2022 | |
| NCT01673204 | Unknown status | Phase 4 | Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy | October 2012 | |
| NCT03413215 | Unknown status | N/A | Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore | March 1, 2019 | December 31, 2022 |
| NCT01005121 | Unknown status | Phase 2 | Colchicine for Diabetic Nephropathy | December 2009 | December 2015 |
| NCT01725412 | Unknown status | Phase 4 | Prevention of Renal Complications of Diabetes With Thiamine | November 2012 | |
| NCT01743014 | Unknown status | Phase 4 | Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy | July 2012 | July 2015 |
| NCT03658317 | Unknown status | N/A | Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy | September 2018 | September 2019 |
| NCT02237352 | Unknown status | Mechanisms of Diabetic Nephropathy in Ecuador | September 15, 2014 | December 2022 | |
| NCT05061459 | Unknown status | The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy | October 2021 | November 2023 | |
| NCT01215994 | Unknown status | Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus. | March 2009 | March 2016 | |
| NCT04127084 | Unknown status | Phase 4 | Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes | October 15, 2019 | August 2021 |
| NCT04562025 | Unknown status | N/A | Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy | September 25, 2020 | December 31, 2021 |
| NCT01307917 | Withdrawn | N/A | Flavonoids in the Treatment of Endothelial Dysfunction in Children With Diabetes | July 2009 | September 2012 |
| NCT02410499 | Withdrawn | Phase 2 | Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria | May 20, 2015 | November 17, 2015 |